NCBiotech News

GreenLight Biosciences, which has a growing research and development presence in Research Triangle Park, has announced additional financing on its journey to becoming a publicly traded company

Durham-based BioCryst Pharmaceuticals has reached agreements that will provide the company with $350 million in funding to support the development of two of its new drugs.

Regulatory authorities in Mexico have approved RTP ag tech company Vestaron’s SPEAR-Lep, a biopesticide that’s already in use in the U.S.

Durham-based Cell Microsystems has received $10 million in financing from life science and venture capital firm Telegraph Hill Partners.

Sheila Mikhail, co-founder and CEO of AskBio and an NCBiotech board member, has been named national Entrepreneur of the Year by Ernst & Young.

Raleigh-based Aceragen, a biopharmaceutical company developing therapeutics for rare and orphan diseases, has acquired Arrevus, another Raleigh company with a similar focus.

Cleanroom design and construction company AdvanceTEC has announced it will invest $10 million in a new prefabrication and modularization facility in Johnston County.

Contract research organization Portrett Pharmaceuticals has launched a new lab in Wilmington that specializes in the analytical testing of small-molecule active pharmaceutical ingredients.

The North Carolina Biotechnology Center awarded 11 grants and loans totaling $779,300 to bioscience companies, universities and non-profit organizations in the first quarter of its fiscal year.

A month after a favorable ruling in a patent dispute, Morrisville-based Liquidia has gained tentative approval from the FDA for Yutrepia, its inhalation powder for treating pulmonary arterial hypertensio

Durham-based Bioventus finalized its acquisition of Misonix making the New York-based provider of therapeutic ultrasound technologies and regenerative medicine a wholly owned subsidiary of the company.

After a 25-year career in the restaurant and automotive sales industries, Chris Carver knew it was time for a change. Today, he is a full-time manufacturing associate in North Carolina's biopharmaceutical industry.

Duke University spinout Istari Oncology is partnering with FUJIFILM Diosynth Biotechnologies to manufacture its promising new cancer treatment based on a polio vaccine.

Metabolon, an RTP precision medicine company, has unveiled a new platform and tool to help visualize the metabolome -- the complete set of small-molecule chemicals found within a biological sample.

Duke University's Office for Translation and Commercialization, which manages Duke-generated innovations and licenses them to commercial partners, has reported the launch of 13 new companies in fiscal year 2021.